Status:
UNKNOWN
Dexmedetomidine for Prevention of Chronic Postoperative Pain
Lead Sponsor:
Zhongda Hospital
Conditions:
Chronic Postoperative Pain
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
Chronic postoperative pain (CPSP) is common symptom in patients after surgery, seriously affected the quality of life. Accumulating evidences have demonstrated dexmedetomidine can improve chronic pain...
Detailed Description
Chronic postoperative pain (CPSP) is defined as pain persisting at least 3 months after surgery. It is most common in patients who undergoing breast or thoracic surgery. Dexmedetomidine, a adrenergic ...
Eligibility Criteria
Inclusion
- Patients must have been 18 to 65 yr old, and been scheduled for breast or thoracic surgery.
Exclusion
- Patients with limitations of self-expression or visual dysfunction or having emergency surgery, a severe psychiatric illness, or chronic pain problems in the chest area for longer than 2 months before the surgery,or patients who could not provide informed consent were excluded.
- Pregnant women and prisoners were also excluded.
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2018
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03275207
Start Date
January 1 2018
End Date
October 1 2018
Last Update
December 5 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhongda Hospital
Nanjing, Jiangsu, China, 210009